Discover 645 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nebraska provides a variety of paid research opportunities for both healthy volunteers and individuals with specific medical concerns. Research institutions in Omaha, Lincoln, and Bellevue are recruiting participants, offering access to advanced treatments and dedicated medical care.
Filter
1
Filter results
Results: 645
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA, Miami FL,
Sponsor: Moleculin Biotech, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06788756
Phase 2, Phase 3, Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia
Location: Shirley NY, Westbury NY, New York NY, Greenfield Park,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
Healthy Children, Healthy Communities: Effectiveness of a Multilevel Rural Community Engagement Model for Improving Children's Dietary Intake in Family Child Care Homes
Randomization of Single vs Multiple Arterial Grafts
for
Coronary Artery Disease, Heart Diseases
Location: Springfield MA, Quebec, New York NY, Brooklyn NY,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18 - 70
Code: NCT03217006
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension (PAH)
Location: Boston MA, Cincinnati OH, Omaha NE, Aurora CO
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318597
Phase 2, Recruiting
Empowering Caregivers to Promote Child Independence
for
Profound Autism
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 10 - 17
Code: NCT07059364
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for
Heart Failure
Location: Quebec, Sherbrooke, New York NY, Trois-Rivieres,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06935370
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876649
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Boston MA, Hackensack NJ, New Brunswick NJ,
Sponsor: CellCentric Ltd.
Sex: All
Age: 18+
Code: NCT07096778
Phase 2, Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
for
Solid Tumors
Location: New York NY, Virginia Beach VA, Bethesda MD,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT06953089
Phase 2, Recruiting
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
for
Multiple Myeloma
Location: New Haven CT, Rochester NY, Omaha NE
Sponsor: Noffar Bar
Sex: All
Age: 18+
Code: NCT06993675
Phase 2, Recruiting
Sentence Prediction in Developmental Language Disorder
for
Developmental Language Disorder
Location: Omaha NE
Sponsor: Father Flanagan's Boys' Home
Sex: All
Age: 5 - 7
Code: NCT07510854
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Boston MA, Hartford CT, The Bronx NY, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase 2, Phase 3, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event